主要研究目的: 1)探讨笑疗法在造血干细胞移植患者移植心理健康及生存质量中的效果。 次要研究目的: 1. 了解造血干细胞移植患者移植后3个月、6个月、1年内的心理健康变化和生存质量水平; 2. 探讨笑疗法在造血干细胞移植患者预后等结局指标中的应用效果。
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Overall survival
Timeframe: 3 months, 6 months, and 1 year
Progression-free survival
Timeframe: 3 months, 6 months, and 1 year
Time to treatment failure
Timeframe: 3 months, 6 months, and 1 year